{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:53:40Z","timestamp":1793620420108,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01A1070896"],"award-info":[{"award-number":["R01A1070896"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI079330"],"award-info":[{"award-number":["R01AI079330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pharmthera.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T04:17:23Z","timestamp":1500956243000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Polymyxins for CNS infections: Pharmacology and neurotoxicity"],"prefix":"10.1016","volume":"181","author":[{"given":"Tony","family":"Velkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongshan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe D.","family":"Ciccotosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cappai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2017.07.012_bb0005","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1128\/AAC.01799-09","article-title":"Serum and cerebrospinal fluid levels of colistin in pediatric patients","volume":"54","author":"Antachopoulos","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: New opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0015","first-page":"3","article-title":"Intrathecal or intraventricular colistin: A review","volume":"24","author":"Bargiacchi","year":"2016","journal-title":"Le Infezioni in Medicina"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s15010-014-0618-0","article-title":"Intrathecal\/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: Case reports and review","volume":"42","author":"Bargiacchi","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0025","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.00035-06","article-title":"CMS is an inactive prodrug of colistin against Pseudomonas aeruginosa","volume":"50","author":"Bergen","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0030","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1021\/acs.jnatprod.6b00286","article-title":"In vitro antibacterial activity of curcumin-polymyxin B combinations against multidrug-resistant bacteria associated with traumatic wound infections","volume":"79","author":"Betts","year":"2016","journal-title":"Journal of Natural Products"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0035","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10 x '20 progress-development of new drugs active against gram-negative bacilli: An update from the IDSA","volume":"56","author":"Boucher","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0040","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.04110-14","article-title":"Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii","volume":"59","author":"Bowers","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2471\/BLT.11.030211","article-title":"Race against time to develop new antibiotics","volume":"89","author":"Braine","year":"2011","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0050","first-page":"3291","article-title":"New pharmacokinetic\/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: Smaller response in lung infection","volume":"70","author":"Cheah","year":"2015","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0055","series-title":"Curcumin attenuates colistin-induced neurotoxicity in N2a cells via anti-inflammatory activity, suppression of oxidative stress, and apoptosis","author":"Dai","year":"2016"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0060","article-title":"Curcumin attenuates colistin-induced neurotoxicity in N2a cells via anti-inflammatory activity, suppression of oxidative stress, and apoptosis","author":"Dai","year":"2016","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkx037","article-title":"Minocycline attenuates colistin-induced neurotoxicity via suppression of apoptosis, mitochondrial dysfunction and oxidative stress","author":"Dai","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.etp.2013.01.008","article-title":"New insight in colistin induced neurotoxicity with the mitochondrial dysfunction in mice central nervous tissues","volume":"65","author":"Dai","year":"2013","journal-title":"Experimental and Toxicologic Pathology"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3109\/15376516.2012.704956","article-title":"Electrophysiology and ultrastructural changes in mouse sciatic nerve associated with colistin sulfate exposure","volume":"22","author":"Dai","year":"2012","journal-title":"Toxicology Mechanisms and Methods"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0080","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1007\/s12035-015-9396-7","article-title":"Colistin-induced apoptosis of neuroblastoma-2a cells involves the generation of reactive oxygen species, mitochondrial dysfunction, and autophagy","volume":"53","author":"Dai","year":"2016","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1592\/phco.26.4.515","article-title":"Minocycline for short-term neuroprotection","volume":"26","author":"Elewa","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0090","series-title":"Clinical breakpoints","author":"EUCAST","year":"2017"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0095","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: Old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2003.12.006","article-title":"Optimal delivery of minocycline to the brain: Implication for human studies of acute neuroprotection","volume":"186","author":"Fagan","year":"2004","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0105","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0110","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1039\/c0nr00758g","article-title":"Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo","volume":"3","author":"Gou","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: Management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: Lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS Journal"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.freeradbiomed.2016.06.024","article-title":"Translocation of iron from lysosomes to mitochondria during acetaminophen-induced hepatocellular injury: Protection by starch-desferal and minocycline","volume":"97","author":"Hu","year":"2016","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0135","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1128\/AAC.00231-12","article-title":"Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate","volume":"56","author":"Imberti","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10096-001-0680-2","article-title":"Cerebrospinal fluid penetration and pharmacokinetic\/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis","volume":"21","author":"Jimenez-Mejias","year":"2002","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0145","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/AAC.01273-10","article-title":"Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice","volume":"55","author":"Jin","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0150","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1128\/AAC.00713-12","article-title":"Effect of systemic infection induced by Pseudomonas aeruginosa on the brain uptake of colistin in mice","volume":"56","author":"Jin","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0155","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1128\/AAC.00765-13","article-title":"Species-dependent blood-brain barrier disruption of lipopolysaccharide: Amelioration by colistin in vitro and in vivo","volume":"57","author":"Jin","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0160","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1469-0691.2009.03019.x","article-title":"Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: A case series and systematic review","volume":"16","author":"Khawcharoenporn","year":"2010","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","volume":"196","author":"Kim","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0175","article-title":"Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy","volume":"72","author":"Koch-Weser J Fau - Sidel","year":"1970","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0185","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1128\/AAC.46.10.3304-3307.2002","article-title":"Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography","volume":"46","author":"Li","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0190","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.47.5.1766-1770.2003","article-title":"Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration","volume":"47","author":"Li","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0205","series-title":"Polymyxin derivatives as antimicrobial compounds","author":"Li","year":"2015"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw172.1589","article-title":"Minocycline (MINO) activity is enhanced by polymyxin B (PmB) in TetB containing isolates of Acinetobacter baumannii (ACB), including those resistant to PmB","volume":"3","author":"Lomovskaya","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0215","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/AAC.00345-09","article-title":"Penetration of colistin into cerebrospinal fluid","volume":"53","author":"Markantonis","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciw839","article-title":"Dosing guidance for intravenous colistin in critically ill patients","volume":"64","author":"Nation","year":"2017","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1473-3099(14)70850-3","article-title":"Framework for optimisation of the clinical use of colistin and polymyxin B: The Prato polymyxin consensus","volume":"15","author":"Nation","year":"2015","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciu213","article-title":"Colistin and polymyxin B: Peas in a pod, or chalk and cheese?","volume":"59","author":"Nation","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0235","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-199835030-00005","article-title":"Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections","volume":"35","author":"Nau","year":"1998","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0245","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jac\/dkl347","article-title":"Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: Case series and literature review","volume":"58","author":"Ng","year":"2006","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0250","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","author":"Organization","year":"2017"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0260","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3171\/2013.6.JNS122126","article-title":"Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and\/or ventriculitis in a serious clinical state","volume":"119","author":"Reme\u0161","year":"2013","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0265","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/cid\/cit334","article-title":"Population PK of intravenous polymyxin B in critically ill patients: Implications for selection of dosage regimens","volume":"57","author":"Sandri","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cmi.2015.09.023","article-title":"Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: Matched cohort study","volume":"22","author":"Shofty","year":"2016","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0275","series-title":"The molecular targets and therapeutic uses of curcumin in health and disease","volume":"vol. 595","year":"2007"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0280","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/fmb.13.39","article-title":"Pharmacology of polymyxins: New insights into an 'old' class of antibiotics","volume":"8","author":"Velkov","year":"2013","journal-title":"Future Microbiology"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0285","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1021\/cb500080r","article-title":"Teaching \u2018old\u2019 polymyxins new tricks: New-generation lipopeptides targeting gram-negative \u2018superbugs\u2019","volume":"9","author":"Velkov","year":"2014","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0290","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4155\/fmc-2016-0091","article-title":"Polymyxins: A new hope in combating gram-negative superbugs?","volume":"8","author":"Velkov","year":"2016","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2017.07.012_bb0295","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1128\/AAC.01461-12","article-title":"Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection","volume":"57","author":"Ziaka","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817301924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817301924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T13:44:50Z","timestamp":1750772690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725817301924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":56,"alternative-id":["S0163725817301924"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.07.012","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymyxins for CNS infections: Pharmacology and neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}